Maven Securities’s Albireo Pharma Inc ALBO Stock Holding History

Maven Securities’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$382K	–	1351
2020 Q4	$382K	Buy	+10,000	New	+$364K	0.04%	395

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Maven Securities's ALBO Position: Q1 2021 in Review

Maven Securities sold out of Albireo Pharma Inc (ALBO) in Q1 2021, closing a stake of 10,000 shares — an estimated $382K sold.

Maven Securities first reported a position in ALBO in Q4 2020 and held it in 1 quarter. The position peaked at $382K in Q4 2020. 100 funds tracked by Wall St. Rank hold ALBO as of Q1 2021.

Maven Securities reported no remaining Albireo Pharma Inc position as of Q1 2021 after selling out during the quarter.
Maven Securities sold 10,000 Albireo Pharma Inc shares in Q1 2021, an estimated $382K.
Maven Securities first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 1 quarter.
Maven Securities's Albireo Pharma Inc position peaked at $382K in Q4 2020.
100 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2021.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.